|
CDYL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.141600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.512200E-02 |
| Normal-vs-Stage2 |
7.129800E-01 |
| Normal-vs-Stage3 |
1.580630E-01 |
| Normal-vs-Stage4 |
1.495390E-01 |
| Stage1-vs-Stage2 |
3.097200E-01 |
| Stage1-vs-Stage3 |
6.143000E-01 |
| Stage1-vs-Stage4 |
7.449800E-01 |
| Stage2-vs-Stage3 |
5.351800E-01 |
| Stage2-vs-Stage4 |
5.110400E-01 |
| Stage3-vs-Stage4 |
9.025000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.839400E-03 |
| Normal-vs-AfricanAmerican |
2.486400E-02 |
| Normal-vs-Asian |
2.002400E-01 |
| Caucasian-vs-AfricanAmerican |
3.878000E-01 |
| Caucasian-vs-Asian |
7.355400E-01 |
| AfricanAmerican-vs-Asian |
3.108800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.445550E-01 |
| Normal-vs-Female |
2.988000E-02 |
| Male-vs-Female |
6.724600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.492170E-02 |
| Normal-vs-Age(41-60Yrs) |
3.551800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.994800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.307000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.879400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.203600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.571000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.619700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.721200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.656800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.755600E-01 |
| Classical-VS-Follicular |
1.86489712561411E-11 |
| Classical-VS-Other |
3.968400E-01 |
| Classical-VS-Normal |
1.623790E-04 |
| Tall-VS-Follicular |
7.7133000000007E-05 |
| Tall-VS-Other |
4.331200E-01 |
| Tall-VS-Normal |
2.826300E-02 |
| Follicular-VS-Other |
1.793160E-01 |
| Follicular-VS-Normal |
5.198500E-03 |
| Other-VS-Normal |
8.140800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.829400E-01 |
| Normal-vs-N1 |
4.372800E-01 |
| N0-vs-N1 |
6.466800E-01 |
|
|
